Medical Properties Trust, Inc. (MPW)
NYSE: MPW · Real-Time Price · USD
4.500
+0.100 (2.27%)
At close: Aug 29, 2025, 4:00 PM
4.520
+0.020 (0.44%)
After-hours: Aug 29, 2025, 7:53 PM EDT
Medical Properties Trust Stock Forecast
Stock Price Forecast
The 7 analysts that cover Medical Properties Trust stock have a consensus rating of "Hold" and an average price target of $5.50, which forecasts a 22.22% increase in the stock price over the next year. The lowest target is $4.00 and the highest is $9.00.
Price Target: $5.50 (+22.22%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Medical Properties Trust stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 4 | 4 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Sell Maintains $5 → $4.5 | Sell | Maintains | $5 → $4.5 | n/a | Aug 27, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $5 → $4.5 | Hold | Maintains | $5 → $4.5 | n/a | Jun 30, 2025 |
| Exane BNP Paribas | Exane BNP Paribas | Hold → Buy Upgrades $5 → $9 | Hold → Buy | Upgrades | $5 → $9 | +100.00% | Mar 12, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $4 → $5 | Hold | Maintains | $4 → $5 | +11.11% | Mar 10, 2025 |
| Wells Fargo | Wells Fargo | Sell Maintains $4 → $5 | Sell | Maintains | $4 → $5 | +11.11% | Mar 10, 2025 |
Financial Forecast
Revenue This Year
949.98M
from 1.04B
Decreased by -8.54%
Revenue Next Year
1.01B
from 949.98M
Increased by 6.21%
EPS This Year
-0.08
from -4.02
EPS Next Year
0.16
from -0.08
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.1B | 1.2B | |||
| Avg | 950.0M | 1.0B | |||
| Low | 865.0M | 911.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.5% | 21.3% | |||
| Avg | -8.5% | 6.2% | |||
| Low | -16.7% | -4.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.25 | 0.29 | |
| Avg | -0.08 | 0.16 | |
| Low | -0.18 | 0.11 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.